Hovinga Collin A, Asato Miya R, Manjunath Ranjani, Wheless James W, Phelps Stephanie J, Sheth Raj D, Pina-Garza Jesus E, Zingaro Wendy M, Haskins Lisa S
University of Tennessee Health Science Center, Memphis, TN 38103, USA.
Epilepsy Behav. 2008 Aug;13(2):316-22. doi: 10.1016/j.yebeh.2008.03.009. Epub 2008 May 9.
Non-adherence to epilepsy medications can interfere with treatment and may adversely affect clinical outcomes, although few studies have examined this relationship. This study assessed barriers and drivers to adherence, its impact on quality of life, and the importance of the patient-physician relationship to adherence. Two cross-sectional online surveys were conducted among 408 adult patients with epilepsy and 175 neurologists who treat epilepsy patients. Twenty-nine percent of patients self-reported being non-adherent to antiepileptic medications in the prior month. Non-adherence was found to be associated with reduced seizure control, lowered quality of life, decreased productivity, seizure-related job loss, and seizure-related motor vehicle accidents. Patient-oriented epilepsy treatment programs and clear communication strategies to promote self-management and patients' understanding of epilepsy are essential to maximizing treatment and quality of life outcomes while also minimizing economic costs.
尽管很少有研究探讨这种关系,但不坚持服用癫痫药物会干扰治疗,并可能对临床结果产生不利影响。本研究评估了坚持服药的障碍和驱动因素、其对生活质量的影响以及医患关系对坚持服药的重要性。对408名成年癫痫患者和175名治疗癫痫患者的神经科医生进行了两项横断面在线调查。29%的患者自我报告在前一个月未坚持服用抗癫痫药物。研究发现,不坚持服药与癫痫控制不佳、生活质量下降、生产力降低、与癫痫相关的失业以及与癫痫相关的机动车事故有关。以患者为导向的癫痫治疗项目和促进自我管理以及患者对癫痫理解的清晰沟通策略对于最大限度地提高治疗效果和生活质量、同时最小化经济成本至关重要。